Background Oral anticoagulation is the cornerstone treatment of several diseases. Its
management is often challenging, and different telemedicine strategies have been …

Background Among patients with nonvalvular atrial fibrillation (AF) and an elevated stroke
risk, guidelines recommend direct oral anticoagulants (DOACs) over warfarin for stroke …

Objective Since 2010, several non–vitamin K antagonist oral anticoagulants (NOACs) have
been brought to the US market, yet little is known regarding their evolving adoption for …

Background Anticoagulation in patients with malignancy and atrial fibrillation is challenging
because of enhanced risks for thrombosis and bleeding and the frequent need for invasive …

Importance Current guidelines recommend against use of intravenous alteplase in patients
with acute ischemic stroke who are taking non–vitamin K antagonist oral anticoagulants …

The best method of anticoagulation for patients with peripheral artery disease (PAD) is still a
topic of interest for physicians. We conducted a meta-analysis to compare the effects of …

Abstract The Perioperative Anticoagulation Use for Surgery Evaluation (PAUSE) study
prospectively evaluated a prespecified periprocedural-interruption strategy of direct oral …

Background and Purpose—Oral anticoagulation therapy is standard of care for patients with
nonvalvular atrial fibrillation to prevent stroke. This study compared rivaroxaban and …

Background. Data directly comparing trends in the use of different oral anticoagulants
(OACs) among patients with atrial fibrillation (AF) from different countries are limited. We …

Background and Purpose—Ischemic stroke (IS) secondary to atrial fibrillation (AF) is largely
preventable with the use of anticoagulation. We sought to identify race-ethnicity and sex …